BDKRB2 and hereditary angioedema: Icatibant, a synthetic bradykinin B2 receptor antagonist, has been shown to be effective for severe ACEI-RA if given within the first 10 hours of symptom onset.12 Medications approved for hereditary angioedema should also be considered in severe cases of ACEI-RA in which intubation is imminent.